Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

GPNMB Mouse anti-Human, Clone: 303822, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA524014

Catalog No. PIMA524014


Add to cart

Description

Description

In direct ELISAs, no cross-reactivity with Recombinant mouse Osteoactivin is observed. Reconstitute at 0.5 mg/mL in sterile PBS.

The protein encoded by this gene is a type I transmembrane glycoprotein which shows homology to the pMEL17 precursor, a melanocyte-specific protein. GPNMB shows expression in the lowly metastatic human melanoma cell lines and xenografts but does not show expression in the highly metastatic cell lines. GPNMB may be involved in growth delay and reduction of metastatic potential. Two transcript variants encoding different isoforms have been found for this gene.
Specifications

Specifications

GPNMB
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
Q14956
HGFIN, NMB, glycoprotein NMB, glycoprotein nmb-like protein, osteoactivin, transmembrane glycoprotein HGFIN, transmembrane glycoprotein NMB
Mouse
IgG2B
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
10457
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot
303822
Unconjugated
GPNMB
Lyophilized
GPNMB
Mouse myeloma cell line NS0-derived recombit human Osteoactivin/GPNMBisoform 2 Ala22-Asn486
Protein A/G
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit